# Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors

> **NCT00003750** · PHASE1 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 28 (actual)

## Conditions studied

- Melanoma (Skin)
- Neuroblastoma
- Sarcoma
- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** hu14.18-IL2 fusion protein

## Key facts

- **NCT ID:** NCT00003750
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** 2005-01
- **Final completion:** 2005-09
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2014-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003750, "Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*